Trials / Completed
CompletedNCT05891860
Virtual Family Participation in ICU Rounds: A Pilot Study
Virtual Family Participation in ICU Rounds (The VR-Family Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Lady Davis Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Barriers to family participation in ICU rounds exist at the health care system level (e.g., restriction on visitation, infection control) and the individual level (e.g., caretaker role, illness, disability, inability to miss work). While virtual family participation in ICU rounds may contribute to addressing these barriers, its feasibility, impact, and effectiveness are yet unknown. The primary objective of this study is to assess the feasibility of virtual family participation in adult ICU rounds. The secondary objectives are: to assess the effect size of virtual family participation in ICU rounds on family engagement, satisfaction, and anxiety and depression; and to explore family and physician experiences of family participation in ICU rounds. This will be a pilot prospective trial of 72 family members at 4 Canadian adult ICUs, with an embedded qualitative study that will sample family members and critical care physicians. The primary outcome will reflect feasibility metrics (i.e., recruitment, uptake, technical, and follow-up). Secondary outcomes include data regarding family engagement, satisfaction, mental health, and perceived experiences of participation in ICU rounds. This study will assess the feasibility of conducting a larger, hypothesis-testing randomized controlled trial to assess virtual family participation in adult ICU rounds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Participation in virtual rounds | Virtual participation in daily ICU team rounds |
Timeline
- Start date
- 2023-06-12
- Primary completion
- 2024-12-30
- Completion
- 2024-12-30
- First posted
- 2023-06-07
- Last updated
- 2025-02-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05891860. Inclusion in this directory is not an endorsement.